Kisqali 600 MG daily dose UU 63S
Ended Awarded
- Contract number
- SPE2DR26FRH7G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,299
Award facts
- Contract value 100% obligated
- $66,298.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $66,298.86 delivery order to Amerisourcebergen Drug Corp on June 18, 2026, for KISQALI 600 mg daily-dose tablets (63 count).
Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of July 13, 2026. No set-aside applies.
Quick answers
Who was awarded contract SPE2DR26FRH7G?
SPE2DR26FRH7G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2026.
How much is contract SPE2DR26FRH7G worth?
The government has obligated $66,299 on SPE2DR26FRH7G.
Is contract SPE2DR26FRH7G an order under another contract?
Yes. SPE2DR26FRH7G is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FRH7G competed?
The extent of competition for SPE2DR26FRH7G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award